While prior research has emphasized the clinical significance of FcγRIIIa-mediated immune activation through IgG1 isotype antibodies, comprehensive investigations of potential interactions between different components of the immune system and their interplay with cancer cells have not been fully explored [1,23]. Here, FCGR3A is linked to cancer.